Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001301120-25-000037

Chief Scientific Officer sold 5,673 shares at $2.67 ($15,168)

  • Chief Scientific Officer acquired 5,673 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moreadith Randall · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-22 Exercise or conversion : show line 1 in the form 10b5-1 +5,673 $0.06 $340 5,673 D
2025-12-22 Sale : show line 2 in the form 10b5-1 −5,673 $2.67 $15,168 0 D
Open-market sales · 5,673 sh · avg $2.67 · $15,168

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-22 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −5,673 356,286 D
Loading xslF345X05/wk-form4_1766516671.xml…